Week 6 Neuro Flashcards
(130 cards)
Parkinson
cardinal features
- bradykinesia
- resting tremor suppressed by movement
- lead pipe rigidity with passive movement
Parkinson
motor features
- resting tremor
- lead pipe rigidity
- bradykinesia
- postural instability
- gait: shuffling
- freezing (initiating, turns, obstacles)
Parkinson
non-motor features
- autonomic dysfunction (bladder, bowels, postural instability)
- dementia
- depression
- sensory (anosmia, paresthesia, pain)
- sleep disturbance (nocturia, stiffness at night, RLS)
Treatment of anxiety in elderly
SSRIs and SNRIs recommended
- which one is well tolerated?
- common side effects?
- increased risk in elderly?
escitalopram, citalopram
SERTRALINE
side effects: GI upset, insomnia, sexual dysfunction, sedation
INCREASE risk GIB if on concurrent NSAIDs
INCREASE risk bone density loss, hip fracture, SIADH
Treatment of anxiety in elderly
SNRI
-venlafaxine side effects
-duloxetine side effects:
venlafaxine: sexual dysfunction, sweating, increase in SBP and DBP
duloxetine: BP not as affected
monitor for urinary retention, sweating
Treatment of anxiety in elderly
TCA - why avoid?
MAOI - why avoid?
TCA: anticholinergic: orthostatic hypotension, falls, urinary retention, confusion, cardiac effects
MAOI: orthostatic hypotension, falls, HTN crisis
are benzos recommended for treatment of anxiety in elderly?
risks»_space;»> benefits
recommend lorazepam, oxazepam or temazepam if MUST be used (metabolized by conjugation)
RISK of falls, hip fracture, cognitive impairment, dementia
treatment of anxiety in elderly
are antipyschotics recommended?
black box warning!
increased mortality esp in elderly with dementia
Quetiapine is effective for GAD
Risk long term use: increase osteopenia, bone loss
features of delirium
AIDA
AIDA
- acute, fluctuating
- inattention
- disorganized thinking
- altered LOC
what neurotransmitters are imbalanced in delirium?
cholinergic deficiency
dopaminergic excess
what drug class is implicated as precipitator and predisposing factor in delirium?
anticholinergics!
esp oxybutynin and diphenhydramine
**think of anticholinergic burden
for hospitalized patients, what are the common modifiable triggers for delirium?
- fluid and electrolyte imbalance
- infection
- drug toxicity
- metabolic d/o
- sensory and environmental problems (eg untreated pain, missing hearing aids or glasses, poor sleep)
Dementia
MMSE ratings:
mild:
moderate:
severe:
mild: 20-26
moderate: 12-29
severe: <12
Death from severe dementia is often a result of what processes?
malnutrition
infections (aspiration pneumonia, pressure ulcers)
Pathophysiology of Alzheimer’s
amyloid beta (ABeta) plaques and tau fibrillary tangles Plaques and tangles cause "downstream" effects: synaptic dysfunction, mitochondrial damage, vascular damage, and inflammation
Alzheimer’s non-modifiable risk factors
- genetics
- family hx
- Down syndrome (APP gene carried on chromosome 21)
- low education
- CKD
- afib
- depression
Dementia modifiable risk factors
what class of meds?
HTN
- CVD
- obesity
- DM
- sedentary lifestyle
- OSA
- social isolation
- ETOH, smoking
- anticholinergic meds, benzo, PPI
- environmental pollutants
- brain trauma
- hearing impairment
Workup of cognitive impairment
Labwork?
B12 level, TSH, HIV, syphilis, metabolic screen, liver enzyme, CBC, lytes
*identify reversible causes
Components of HISTORY differentiating between:
- MCI
- Alzheimer’s
MCI: cognitive deficits across one or more domains
Alzheimer’s progressive memory loss and other cognitive deficits
-impact on ADL and IADL
Components of HISTORY differentiating between:
Vascular dementia
Lewy Body dementia
vascular: hx vascular risk factors: eg hx of stroke/TIA
* executive function as prominent early symptom
* can commonly present WITH Alzheimer’s (Mixed dementia)
Lewy body:
-well formed visual hallucinations, REM sleep disorder, falls, fluctuating cognition
Dementia DDX
- depression
- OSA
- NPH
- subclinical seizures
- SDH
- untreated hearing and vision impairment
- side effect of anticholinergic meds
Treatment of Dementia
NO disease modifying or curative drug therapies for MCI, AD or other dementia
goal is to improve QoL
support autonomy
Person-Centered Care Framework
Informed decision making and self-determination
side effects associated with cholinesterase inhibitors (donepezil, galantamine, rivastigmine)
GI distress wt loss urinary urgency BRADYCARDIA, syncope sleep disturbances (vivid dreams)
side effects associated with NDMA receptor inhibitors (memantine)
Fewer s/e but can be dizzy, hallucinations, and increased agitation